Rainer H. Böger

Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction

Rainer H. Böger, Stefanie M. Bode‐Böger, Andrzej Szuba et al. · Circulation · 1998 · 1.2K citations · Full text

Vascular Disease, Cardiovascular Disease, Medicine +15

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

Carmine Zoccali, Stefanie M. Bode‐Böger, Francesca Mallamaci et al. · The Lancet · 2001 · 1.1K citations

Urology, Renal Function, Kidney Failure +9

Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone)

Joseph V. Pergolizzi, Rainer H. Böger, Keith Budd et al. · Pain Practice · 2008 · 851 citations

Opioid Epidemic, Pain Disorders, Pain Medicine +20

Biochemical Evidence for Impaired Nitric Oxide Synthesis in Patients With Peripheral Arterial Occlusive Disease

Rainer H. Böger, Stefanie M. Bode‐Böger, W Thiele et al. · Circulation · 1997 · 492 citations

Pharmacokinetic and pharmacodynamic properties of oral L‐citrulline and L‐arginine: impact on nitric oxide metabolism

Edzard Schwedhelm, Renke Maas, Ralf Freese et al. · British Journal of Clinical Pharmacology · 2007 · 487 citations · Full text